Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | HA14-1 |
Synonyms | |
Therapy Description |
HA14-1 is a BCL2 antagonist, which may induce tumor cell apoptosis and increase sensitivity to chemotherapeutics (PMID: 16510597, PMID: 16213584, PMID: 32079453). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
HA14-1 | BCL2 inhibitor 27 | HA14-1 is a BCL2 antagonist, which may induce tumor cell apoptosis and increase sensitivity to chemotherapeutics (PMID: 16510597, PMID: 16213584, PMID: 32079453). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|